| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 7.0K | 12.4% | 24.2% |
| Total Income | 7.1K | 12.4% | 24.9% |
| Expenditure | 5.1K | 4.0% | 10.1% |
| PBT | 2.0K | 41.8% | 90.3% |
| Net Profit | 1.5K | 21.6% | 72.8% |
| OPM | 33.22% | 5.67pp | 21.15pp |
| NPM | 20.80% | 1.56pp | 5.76pp |
| EPS | 32.36 | 21.2% | 73.0% |
Lupin Ltd Announces Q2 and H1 Results for FY2025-26, Reveals Exceptional Items and Dividend Disbursement
06 Nov 2025 · 6 Nov 2025, 06:44 pm
Summary
Lupin Ltd has announced its Q2 and H1 results for the financial year 2025-26. The company has reported a significant gain on divestment of its Over the Counter (OTC) and API R&D business in India. A final dividend of 12% per equity share has been disbursed. The company has also provided for diminution in the value of investment in a subsidiary.
Key Highlights
- 1
Q2 and H1 results for FY2025-26 announced
- 2
Significant gain on divestment of OTC and API R&D business in India
- 3
Final dividend of 12% per equity share disbursed
- 4
Provided for diminution in the value of investment in a subsidiary
Management Comments
Not provided
The document does not contain any management comments.
Informational and educational content only. Not investment advice.